144 related articles for article (PubMed ID: 8813581)
1. Electrophysiological effects of a cannabinoid on neural activity in the globus pallidus.
Miller AS; Walker JM
Eur J Pharmacol; 1996 May; 304(1-3):29-35. PubMed ID: 8813581
[TBL] [Abstract][Full Text] [Related]
2. Local effects of cannabinoids on spontaneous activity and evoked inhibition in the globus pallidus.
Miller AS; Walker JM
Eur J Pharmacol; 1998 Jul; 352(2-3):199-205. PubMed ID: 9716355
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoids depress excitatory neurotransmission between the subthalamic nucleus and the globus pallidus.
Freiman I; Szabo B
Neuroscience; 2005; 133(1):305-13. PubMed ID: 15893652
[TBL] [Abstract][Full Text] [Related]
4. Effects of a cannabinoid on spontaneous and evoked neuronal activity in the substantia nigra pars reticulata.
Miller AS; Walker JM
Eur J Pharmacol; 1995 Jun; 279(2-3):179-85. PubMed ID: 7556399
[TBL] [Abstract][Full Text] [Related]
5. Effects of exogenous and endogenous cannabinoids on GABAergic neurotransmission between the caudate-putamen and the globus pallidus in the mouse.
Engler B; Freiman I; Urbanski M; Szabo B
J Pharmacol Exp Ther; 2006 Feb; 316(2):608-17. PubMed ID: 16214880
[TBL] [Abstract][Full Text] [Related]
6. Systemic effect of cannabinoids on the spontaneous firing rate of locus coeruleus neurons in rats.
Mendiguren A; Pineda J
Eur J Pharmacol; 2006 Mar; 534(1-3):83-8. PubMed ID: 16483566
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid agonists stimulate [3H]GABA release in the globus pallidus of the rat when G(i) protein-receptor coupling is restricted: role of dopamine D2 receptors.
Gonzalez B; Paz F; Florán L; Aceves J; Erlij D; Florán B
J Pharmacol Exp Ther; 2009 Mar; 328(3):822-8. PubMed ID: 19106171
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of small intestinal secretion by cannabinoids is CB1 receptor-mediated in rats.
Tyler K; Hillard CJ; Greenwood-Van Meerveld B
Eur J Pharmacol; 2000 Dec; 409(2):207-11. PubMed ID: 11104836
[TBL] [Abstract][Full Text] [Related]
9. Paradoxical action of the cannabinoid WIN 55,212-2 in stimulated and basal cyclic AMP accumulation in rat globus pallidus slices.
Maneuf YP; Brotchie JM
Br J Pharmacol; 1997 Apr; 120(8):1397-8. PubMed ID: 9113356
[TBL] [Abstract][Full Text] [Related]
10. Increase in meso-prefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoids.
Diana M; Melis M; Gessa GL
Eur J Neurosci; 1998 Sep; 10(9):2825-30. PubMed ID: 9758152
[TBL] [Abstract][Full Text] [Related]
11. Presynaptic inhibition of GABAergic inputs to rat substantia nigra pars reticulata neurones by a cannabinoid agonist.
Chan PK; Chan SC; Yung WH
Neuroreport; 1998 Mar; 9(4):671-5. PubMed ID: 9559936
[TBL] [Abstract][Full Text] [Related]
12. GABAergic control of rat substantia nigra dopaminergic neurons: role of globus pallidus and substantia nigra pars reticulata.
Celada P; Paladini CA; Tepper JM
Neuroscience; 1999 Mar; 89(3):813-25. PubMed ID: 10199615
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoids modulate neuronal firing in the rat basolateral amygdala: evidence for CB1- and non-CB1-mediated actions.
Pistis M; Perra S; Pillolla G; Melis M; Gessa GL; Muntoni AL
Neuropharmacology; 2004 Jan; 46(1):115-25. PubMed ID: 14654103
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid receptor-independent actions of the aminoalkylindole WIN 55,212-2 on trigeminal sensory neurons.
Price TJ; Patwardhan A; Akopian AN; Hargreaves KM; Flores CM
Br J Pharmacol; 2004 May; 142(2):257-66. PubMed ID: 15155534
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors.
Gessa GL; Melis M; Muntoni AL; Diana M
Eur J Pharmacol; 1998 Jan; 341(1):39-44. PubMed ID: 9489854
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the effect of cannabinoids on GABAergic neurotransmission in the substantia nigra pars reticulata.
Wallmichrath I; Szabo B
Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):326-34. PubMed ID: 11919658
[TBL] [Abstract][Full Text] [Related]
17. Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons.
Huang CC; Lo SW; Hsu KS
J Physiol; 2001 May; 532(Pt 3):731-48. PubMed ID: 11313442
[TBL] [Abstract][Full Text] [Related]
18. Topical cannabinoid agonist, WIN55,212-2, reduces cornea-evoked trigeminal brainstem activity in the rat.
Bereiter DA; Bereiter DF; Hirata H
Pain; 2002 Oct; 99(3):547-556. PubMed ID: 12406531
[TBL] [Abstract][Full Text] [Related]
19. Suppression of noxious stimulus-evoked activity in the ventral posterolateral nucleus of the thalamus by a cannabinoid agonist: correlation between electrophysiological and antinociceptive effects.
Martin WJ; Hohmann AG; Walker JM
J Neurosci; 1996 Oct; 16(20):6601-11. PubMed ID: 8815936
[TBL] [Abstract][Full Text] [Related]
20. Striatal, pallidal, and pars reticulata evoked inhibition of nigrostriatal dopaminergic neurons is mediated by GABA(A) receptors in vivo.
Paladini CA; Celada P; Tepper JM
Neuroscience; 1999 Mar; 89(3):799-812. PubMed ID: 10199614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
